4.8 • 2.7K Ratings
🗓️ 19 December 2023
⏱️ 74 minutes
🧾️ Download transcript
Today, Paul has Dave Feldman on the podcast to discuss, in depth, a recent study that he conducted about LDL and cardiovascular risk and what this may mean for the future of medicine.
*Produced by Mountain Valley Media
00:03:30 The genesis of Dave’s most recent study
00:07:00 is FH a phenotype or genotype polygenetic vs monogenetic
00:22:30 Dave’s overall perspective while conducting studies
0:24:00 Diving into Dave Feldman’s most recent study: Does APOE-B cause atherosclerosis
00:42:30 How the medical community has received this study
00:46:30 Do credentials matter?
00:58:30 Thoughts on Statins
01:04:45 What alters lipid levels
01:13:30 Connect with Dave
References:
Twitter: @realdavefeldman
Instagram: @realdavefeldman
Youtube: youtube.com/@realdavefeldman
Click on a timestamp to play from that location
0:00.0 | there's just no correlation between detected |
0:03.4 | LDL levels at baseline and resulting plaque. |
0:07.0 | On this week's podcast, I had the pleasure of talking to my friend |
0:09.9 | Dave Feldman. |
0:11.1 | Dave recently released a study |
0:13.4 | that was done with Dr Matthew Boudoff, |
0:15.4 | a well-known cardiac radiologist |
0:18.1 | at the Munquoise Institute connected with UCLA |
0:20.6 | looking at the progression of heart disease after risk |
0:24.3 | sclerosis in a cohort of people with elevated LDO and comparing that to a |
0:28.9 | cohort of healthy individuals who didn't have elevated LDL. Let you guys listen to the podcast to hear about the |
0:34.4 | results but I think they are striking. The kind of things I've been talking about for a |
0:37.8 | long time on this podcast, contextual ideas around LDL and ApoB in relation to cardiovascular risk. |
0:44.0 | These findings are quite striking and I think that they raise a lot of important questions. |
0:48.0 | And I hope they are at the beginning of a lot of important research for all of us |
0:52.0 | so that we can truly understand how to best decrease |
0:55.2 | our risk of cardiovascular disease moving forward. Enjoy the podcast with Dave Feldman. These results are striking. |
1:01.9 | Dave Feldman, thanks for coming back on the podcast, man. |
1:04.0 | Yeah, thanks for having me, Paul. |
1:07.0 | Again, I blew the best joke of the podcast just right before the podcast. |
1:12.0 | I'm so excited to talk about this study that you just released with Matt Boudoff and the Lundquist Institute and right as we were starting the podcast I said |
1:22.0 | congratulations on the new child. |
... |
Transcript will be available on the free plan in -464 days. Upgrade to see the full transcript now.
Disclaimer: The podcast and artwork embedded on this page are from Paul Saladino, MD, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Paul Saladino, MD and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.